Bromperidol maintenance in schizophrenia.

J. P. McEvoy, W. H. Wilson, T. A. Ban, J. O. Brannen, S. Berney

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

Original languageEnglish (US)
Pages (from-to)95-96
Number of pages2
JournalPharmacopsychiatria
Volume15
Issue number3
StatePublished - May 1 1982

Fingerprint

Schizophrenia
Maintenance
Haloperidol
Clinical Trials
bromperidol
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McEvoy, J. P., Wilson, W. H., Ban, T. A., Brannen, J. O., & Berney, S. (1982). Bromperidol maintenance in schizophrenia. Pharmacopsychiatria, 15(3), 95-96.

Bromperidol maintenance in schizophrenia. / McEvoy, J. P.; Wilson, W. H.; Ban, T. A.; Brannen, J. O.; Berney, S.

In: Pharmacopsychiatria, Vol. 15, No. 3, 01.05.1982, p. 95-96.

Research output: Contribution to journalArticle

McEvoy, JP, Wilson, WH, Ban, TA, Brannen, JO & Berney, S 1982, 'Bromperidol maintenance in schizophrenia.', Pharmacopsychiatria, vol. 15, no. 3, pp. 95-96.
McEvoy JP, Wilson WH, Ban TA, Brannen JO, Berney S. Bromperidol maintenance in schizophrenia. Pharmacopsychiatria. 1982 May 1;15(3):95-96.
McEvoy, J. P. ; Wilson, W. H. ; Ban, T. A. ; Brannen, J. O. ; Berney, S. / Bromperidol maintenance in schizophrenia. In: Pharmacopsychiatria. 1982 ; Vol. 15, No. 3. pp. 95-96.
@article{735b44a4115b48598cdacc7e077d74c3,
title = "Bromperidol maintenance in schizophrenia.",
abstract = "Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.",
author = "McEvoy, {J. P.} and Wilson, {W. H.} and Ban, {T. A.} and Brannen, {J. O.} and S. Berney",
year = "1982",
month = "5",
day = "1",
language = "English (US)",
volume = "15",
pages = "95--96",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Bromperidol maintenance in schizophrenia.

AU - McEvoy, J. P.

AU - Wilson, W. H.

AU - Ban, T. A.

AU - Brannen, J. O.

AU - Berney, S.

PY - 1982/5/1

Y1 - 1982/5/1

N2 - Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

AB - Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

UR - http://www.scopus.com/inward/record.url?scp=0020133571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020133571&partnerID=8YFLogxK

M3 - Article

C2 - 7100263

AN - SCOPUS:0020133571

VL - 15

SP - 95

EP - 96

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

IS - 3

ER -